Thought Leader Series: Risks and rewards: getting new medications into the hands of patients, Carlo Montagner
Update: 2022-09-01
Description
Carlo Montagner
Co-Founder and CEO, Specialised Therapeutics Australia
Risks and rewards: getting new medications into the hands of patients
In this episode, RCA Chief Executive Richard Vines speaks to Carlo Montagner about:
- His move from psychology to pharma
- Building a strong foundation in the industry
- Founding STA with his wife
- The barriers to, and costs of, supplying drugs in Australia
- How the process can be improved and simplified
- Accessing drugs not listed on the PBS
- The responsibility of clinicians around reimbursement
- The challenges and opportunities of Health Technology Assessment (HTA)
- Why STA is expanding into Asia
- His family’s personal experience with rare cancer
- Why he is passionate about bringing rare cancer drugs to Australia
- His vision for the future
More about Carlo Montagner: Specialised Therapeutics Australia (STA) is a pharmaceutical company that has been instrumental in helping Australians living with rare cancer to access new medications that would otherwise be out of reach. Before co-founding STA, Carlo held senior roles at some of the world’s largest pharmaceutical companies. #thoughtleaderseries
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
